Huntington's Disease
- 1 November 1978
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 35 (11) , 728-730
- https://doi.org/10.1001/archneur.1978.00500350032006
Abstract
• Gamma-aminobutyric acid (GABA) was measured by the ion-exchange fluorometric method in CSF from 22 individuals at risk for Huntington's disease (HD), six individuals with HD, and five neurologically normal controls. The mean (± SD) GABA level in the specimens from patients with HD was 142 ± 27 pmoles/ ml, whereas that of the normal control specimens was 297 ± 87 pmoles/ml. The mean GABA level of the specimens from the individuals at risk for HD was 209 ± 79 pmoles/ml; however, nine of these were in the normal range with a mean value of 281 ± 72 pmoles/ml, while the other 13 were below the normal range with a mean value of 159 ± 27 pmoles/ ml. The data indicate that low GABA levels in CSF are evident prior to the onset of symptoms of HD but a predictive value can only be determined by continued observation of the clinical course of these at-risk individuals.This publication has 5 references indexed in Scilit:
- Verification and quantification of GABA in human cerebrospinal fluidJournal of Neurochemistry, 1978
- Cerebrospinal Fluid -Aminobutyric Acid Variations in Neurological DisordersArchives of Neurology, 1977
- Is GABA detectable in human CSF?Journal of Neurochemistry, 1976
- Measurement of GABA in human cerebrospinal fluidBiochemical Medicine, 1975
- Column chromatography of amino acids with fluorescence detectionJournal of Chromatography A, 1973